• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

JDS Pharmaceuticals

Anonymous board for JDS Pharmaceuticals
Replies
6
Views
5K
anonymous
Replies
3
Views
4K
anonymous
Replies
4
Views
8K
Anonymous
Replies
3
Views
6K
Anonymous
Replies
2
Views
6K
Anonymous
Replies
2
Views
7K
Anonymous